Overview

A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option

Status:
Not yet recruiting

Trial end date:
2027-01-31

Target enrollment:

Participant gender:

Summary

The purpose of the study is to enable participants with pulmonary hypertension (PH) currently treated with study intervention(s) in a clinical study (parent studies [NCT03422328, NCT03904693 and NCT04565990]), to continue to benefit from the intervention after closure of the parent study in case they have no alternative means of access to the study intervention. This study will allow assessment of the long-term safety of each study intervention. .

Phase:

Phase 3

Details

Lead Sponsor:

Actelion

Treatments:

Macitentan
Selexipag
Tadalafil